AnaptysBio
Latest round
- Series D
Last raised
- Jul 2015
Total raised
- $85M
Investors
- 11
About AnaptysBio
AnaptysBio, Inc.Founded in 2005 and headquartered in San Diego, US, AnaptysBio, Inc. specializes in developing immunology therapies.AnaptysBio, Inc. develops innovative immunology therapeutics, including rosnilimab, which targets PD-1+ T cells and is in clinical trials for rheumatoid arthritis and ulcerative colitis.AnaptysBio, Inc. The company aims to utilize strategic partnerships for further development and commercialization of its therapies.
Who invested in AnaptysBio
11 investors across 5 rounds
See all investors in AnaptysBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AnaptysBio
Who invested in AnaptysBio?
AnaptysBio has 11 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AnaptysBio raised?
AnaptysBio has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did AnaptysBio last raise money?
AnaptysBio's most recent round on record is a Series D, in Jul 2015.
What does AnaptysBio do?
AnaptysBio is a pharmaceuticals company.
Where is AnaptysBio headquartered?
AnaptysBio is headquartered in San Diego, US.
Which VCs invest in companies like AnaptysBio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at AnaptysBio's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like AnaptysBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.